Wrenne Financial Planning’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Hold
930
0.08% 53
2026
Q1
$202K Hold
930
0.08% 49
2025
Q4
$213K Hold
930
0.09% 47
2025
Q3
$215K Buy
+930
New +$189K 0.09% 44
2024
Q4
Sell
-1,218
Closed -$241K 42
2024
Q3
$241K Sell
1,218
-8
-0.7% -$1.49K 0.14% 37
2024
Q2
$210K Buy
+1,226
New +$203K 0.15% 36

Other funds holding ABBV

Wrenne Financial Planning's ABBV Position: Q2 2026 in Review

Wrenne Financial Planning held its AbbVie (ABBV) position steady in Q2 2026 at 930 shares worth $234K. The position accounts for 0.08% of the portfolio, ranked #53.

Wrenne Financial Planning first reported a position in ABBV in Q2 2024 and has held it in 6 quarters since. The position peaked at $241K in Q3 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wrenne Financial Planning held 930 shares of AbbVie worth $234K as of Q2 2026.
  • Wrenne Financial Planning left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.08% of Wrenne Financial Planning's portfolio in Q2 2026, its #53 holding.
  • Wrenne Financial Planning first reported a position in AbbVie in Q2 2024 and has held it in 6 quarters since.
  • Wrenne Financial Planning's AbbVie position peaked at $241K in Q3 2024.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wrenne Financial Planning's 13F filing for Q2 2026, filed 27 Jul 2026.